• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘草提取物漂浮片的制剂与评价

Formulation and evaluation of floating tablets of liquorice extract.

作者信息

Ram H N Aswatha, Lachake Prachiti, Kaushik Ujjwal, Shreedhara C S

机构信息

Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal - 576 104, Karnataka, India.

出版信息

Pharmacognosy Res. 2010 Sep;2(5):304-8. doi: 10.4103/0974-8490.72329.

DOI:10.4103/0974-8490.72329
PMID:21589757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3093044/
Abstract

BACKGROUND

Floating tablets prolong the gastric residence time of drugs, improve bioavailability, and facilitate local drug delivery to the stomach. With this objective, floating tablets containing aqueous extract of liquorice as drug was prepared for the treatment of Helicobacter pylori and gastric ulcers.

METHODS

The aqueous extract of liquorice was standardized by HPTLC. Tablets containing HPMC K100M (hydrophilic polymer), liquorice extract, sodium bicarbonate (gas generating agent), talc, and magnesium stearate were prepared using direct compression method. The formulations were evaluated for physical parameters like diameter, thickness, hardness, friability, uniformity of weight, drug content, buoyancy time, dissolution, and drug release mechanism. The formulations were optimized on the basis of buoyancy time and in vitro drug release.

RESULTS

The diameter of all formulations was in the range 11.166-11.933 mm; thickness was in the range 4.02-4.086 mm. The hardness ranged from 3.1 to 3.5 kg/cm(2). All formulations passed the USP requirements for friability and uniformity of weight. The buoyancy time of all tablet formulations was less than 5 min and tablet remained in floating condition throughout the study. All the tablet formulations followed zero-order kinetics and Korsemeyer-Peppas model in drug release.

CONCLUSION

The optimized formulation was found to be F6 which released 98.3% of drug in 8 h in vitro, while the buoyancy time was 3.5 min. Formulations containing psyllium husk, sodium bicarbonate and HPMC K100M in combination can be a promising for gastroretentive drug delivery systems.

摘要

背景

漂浮片可延长药物在胃内的停留时间,提高生物利用度,并便于药物在胃部局部给药。基于此目的,制备了含甘草水提取物的漂浮片用于治疗幽门螺杆菌和胃溃疡。

方法

采用高效薄层色谱法对甘草水提取物进行标准化。使用直接压片法制备含有羟丙基甲基纤维素K100M(亲水性聚合物)、甘草提取物、碳酸氢钠(产气剂)、滑石粉和硬脂酸镁的片剂。对制剂的物理参数进行评估,如直径、厚度、硬度、脆碎度、重量均匀度、药物含量、漂浮时间、溶出度和药物释放机制。基于漂浮时间和体外药物释放对制剂进行优化。

结果

所有制剂的直径在11.166 - 11.933毫米范围内;厚度在4.02 - 4.086毫米范围内。硬度范围为3.1至3.5千克/平方厘米。所有制剂均符合美国药典对脆碎度和重量均匀度的要求。所有片剂制剂的漂浮时间均小于5分钟,且在整个研究过程中片剂保持漂浮状态。所有片剂制剂在药物释放方面均遵循零级动力学和 Korsemeyer - Peppas模型。

结论

发现优化后的制剂为F6,其在体外8小时内释放了98.3%的药物,而漂浮时间为3.5分钟。含有车前子壳、碳酸氢钠和羟丙基甲基纤维素K100M的组合制剂对于胃滞留药物递送系统可能具有前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9115/3093044/1bc83abf1029/PR-2-304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9115/3093044/eec65bd545f6/PR-2-304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9115/3093044/f1d25090d29d/PR-2-304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9115/3093044/1bc83abf1029/PR-2-304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9115/3093044/eec65bd545f6/PR-2-304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9115/3093044/f1d25090d29d/PR-2-304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9115/3093044/1bc83abf1029/PR-2-304-g003.jpg

相似文献

1
Formulation and evaluation of floating tablets of liquorice extract.甘草提取物漂浮片的制剂与评价
Pharmacognosy Res. 2010 Sep;2(5):304-8. doi: 10.4103/0974-8490.72329.
2
Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.用于根除幽门螺杆菌的胃滞留型左氧氟沙星漂浮微丸胶囊系统的设计与评价
Saudi Pharm J. 2014 Dec;22(6):570-9. doi: 10.1016/j.jsps.2014.02.009. Epub 2014 Mar 6.
3
Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.诺氟沙星缓释漂浮药物递送系统的研制:体外与体内评价
PDA J Pharm Sci Technol. 2011 May-Jun;65(3):198-206. doi: 10.5731/pdajpst.2011.00685.
4
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.克拉霉素多单元漂浮药物递送系统的研发:制剂、采用改良溶出装置的体外溶出度研究、人体志愿者体内影像学研究
Drug Res (Stuttg). 2017 Jul;67(7):412-418. doi: 10.1055/s-0043-102952. Epub 2017 Apr 27.
5
Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension.用于治疗高血压的胃滞留漂浮双层片的制剂与评价
Heliyon. 2020 Nov 13;6(11):e05459. doi: 10.1016/j.heliyon.2020.e05459. eCollection 2020 Nov.
6
Formulation and evaluation of floating matrix tablet of stavudine.司他夫定胃漂浮型骨架片的研制与评价
Int J Pharm Investig. 2012 Apr;2(2):83-9. doi: 10.4103/2230-973X.100047.
7
Formulation and evaluation of famotidine floating tablets.法莫替丁胃漂浮片的处方设计与评价
Curr Drug Deliv. 2007 Jan;4(1):51-5. doi: 10.2174/156720107779314730.
8
Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.盐酸地尔硫䓬口腔漂浮型骨架片制剂的研制与体外评价
AAPS PharmSciTech. 2007 Sep 7;8(3):E73. doi: 10.1208/pt0803073.
9
Design, preparation, and evaluation of gastroretentive floating matrix tablet of mitiglinide.米格列奈胃内滞留漂浮型骨架片的设计、制备及评价
Front Pharmacol. 2023 Mar 15;14:1140351. doi: 10.3389/fphar.2023.1140351. eCollection 2023.
10
Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug.以盐酸雷尼替丁为模型药物的羟丙基甲基纤维素和聚环氧乙烷胃漂浮片的制剂与体外评价
J Young Pharm. 2012 Oct;4(4):201-8. doi: 10.4103/0975-1483.104363.

引用本文的文献

1
Phytochemistry, pharmacological activity, and potential health benefits of .[具体植物或物质名称]的植物化学、药理活性及潜在健康益处
Heliyon. 2021 Jun 7;7(6):e07240. doi: 10.1016/j.heliyon.2021.e07240. eCollection 2021 Jun.
2
Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review.甘草(Glycyrrhiza glabra):植物化学成分与药理学研究综述。
Phytother Res. 2018 Dec;32(12):2323-2339. doi: 10.1002/ptr.6178. Epub 2018 Aug 17.
3
Standardization of some herbal antidiabetic drugs in polyherbal formulation.多草药配方中某些草药抗糖尿病药物的标准化。

本文引用的文献

1
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.1. 药物递送分析指数模型述评:原创研究文章:溶质释放描述的一个简单方程:I II. 平板、球体、圆柱体或圆盘形式的非溶胀装置中的菲克和非菲克释放,1987年。
J Control Release. 2014 Sep 28;190:31-2.
2
Floating drug delivery systems: a review.漂浮药物递送系统:综述
AAPS PharmSciTech. 2005 Oct 19;6(3):E372-90. doi: 10.1208/pt060347.
3
Licorice: a possible anti-inflammatory and anti-ulcer drug.
Pharmacognosy Res. 2011 Jan;3(1):49-56. doi: 10.4103/0974-8490.79116.
甘草:一种可能的抗炎和抗溃疡药物。
AAPS PharmSciTech. 2005 Sep 20;6(1):E74-82. doi: 10.1208/pt060113.
4
Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy.控制漂浮型骨架胶囊浮力和胃滞留能力的因素:重新审视争议的新数据
J Pharm Sci. 1994 Jan;83(1):18-24. doi: 10.1002/jps.2600830106.
5
Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules.源自传统片剂和胶囊体外测试的溶解时间百分比图的解读。
J Pharm Sci. 1969 Oct;58(10):1253-7. doi: 10.1002/jps.2600581021.
6
Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo.生胃酮和去甘草甜素的甘草对大鼠胃黏膜前列腺素的体外合成几乎没有影响。
Br J Pharmacol. 1985 Nov;86(3):693-5. doi: 10.1111/j.1476-5381.1985.tb08947.x.
7
Antiulcer activities of glycyrrhetinic acid derivatives in experimental gastric lesion models.甘草次酸衍生物在实验性胃损伤模型中的抗溃疡活性
Chem Pharm Bull (Tokyo). 1989 Sep;37(9):2500-4. doi: 10.1248/cpb.37.2500.